Grufity logo
Grufity logo

Latest FARALLON CAPITAL MANAGEMENT LLC Stock Portfolio

$17.54Billion | No. of Holdings #167

FARALLON CAPITAL MANAGEMENT LLC Performance

2026 Q1-4.90%
YTD-4.90%
2025+14.69%

About FARALLON CAPITAL MANAGEMENT LLC and 13F Hedge Fund Stock Holdings

FARALLON CAPITAL MANAGEMENT LLC is a hedge fund based in San Francisco, CA. On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, FARALLON CAPITAL MANAGEMENT LLC reported an equity portfolio of $17.5 Billions as of 31 Mar, 2026. <br><br> The top stock holdings of FARALLON CAPITAL MANAGEMENT LLC are RVMD, AMZN, MSFT. The fund has invested 7.5% of it's portfolio in REVOLUTION MEDICINES INC and 5% of portfolio in AMAZON COM INC. <br><br> The fund managers got completely rid off EXACT SCIENCES CORP (EXAS), CYBERARK SOFTWARE LTD (CYBR) and SALESFORCE INC (CRM) stocks. They significantly reduced their stock positions in HIMS & HERS HEALTH INC (HIMS), ABIVAX SA and TERNS PHARMACEUTICALS INC (TERN). FARALLON CAPITAL MANAGEMENT LLC opened new stock positions in DIANTHUS THERAPEUTICS INC, MERCK & CO INC (MRK) and ACADIA HEALTHCARE COMPANY IN (ACHC). The fund showed a lot of confidence in some stocks as they added substantially to ROIVANT SCIENCES LTD (ROIV), VAXCYTE INC (PCVX) and TWIST BIOSCIENCE CORP (TWST).
FARALLON CAPITAL MANAGEMENT LLC Equity Portfolio Value
Last Reported on: 15 May, 2026
$17.54Billion
  as of May 15, 2026

FARALLON CAPITAL MANAGEMENT LLC Annual Return Estimates Vs S&P 500

Our best estimate is that FARALLON CAPITAL MANAGEMENT LLC made a return of -4.9% in the last quarter. In trailing 12 months, it's portfolio return was 13.14%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
dianthus therapeutics inc70,157,100
astrazeneca plc44,670,100
vnet group inc44,515,600
merck & co inc43,424,700
acadia healthcare company in40,623,800
johnson & johnson36,177,100
strategy inc32,877,300
netease com inc32,599,100
New stocks bought by FARALLON CAPITAL MANAGEMENT LLC

Additions

Ticker% Inc.
roivant sciences ltd26,048
vaxcyte inc25,120
twist bioscience corp18,562
immunovant inc12,783
cg oncology inc8,325
brightspring health svcs inc7,250
teva pharmaceutical inds ltd785
mastercard incorporated151
Additions to existing portfolio by FARALLON CAPITAL MANAGEMENT LLC

Reductions

Ticker% Reduced
hims & hers health inc-99.7
abivax sa-99.48
terns pharmaceuticals inc-98.91
encompass health corp-98.72
oscar health inc-95.83
genedx holdings corp-92.86
guardant health inc-92.66
vnet group inc-90.08
FARALLON CAPITAL MANAGEMENT LLC reduced stake in above stock

Sold off

Ticker$ Sold
exact sciences corp-650,492,000
new york times co-227,745,000
avidity biosciences inc-233,196,000
nasdaq inc-290,342,000
dayforce inc-202,293,000
ishares bitcoin trust etf-106,107,000
verastem inc-15,440,000
ishares ethereum tr-33,218,900
FARALLON CAPITAL MANAGEMENT LLC got rid off the above stocks

Sector Distribution

FARALLON CAPITAL MANAGEMENT LLC has about 54.9% of it's holdings in Healthcare sector.

  • Healthcare
  • Financial Services
  • Technology
  • Consumer Cyclical
  • Others
  • Industrials
  • Communication Services
Sector%
Healthcare54.9
Financial Services13.8
Technology12.7
Consumer Cyclical5.9
Others4.5
Industrials4.4
Communication Services3.4

Market Cap. Distribution

FARALLON CAPITAL MANAGEMENT LLC has about 75.4% of it's portfolio invested in the large-cap and mega-cap stocks.

  • LARGE-CAP
  • MEGA-CAP
  • MID-CAP
  • UNALLOCATED
  • SMALL-CAP
Category%
LARGE-CAP51.6
MEGA-CAP23.8
MID-CAP15.7
UNALLOCATED4.5
SMALL-CAP4.2

Stocks belong to which Index?

About 78.2% of the stocks held by FARALLON CAPITAL MANAGEMENT LLC either belong to S&P 500 or RUSSELL 2000 index.

  • S&P 500
  • RUSSELL 2000
  • Others
Index%
S&P 50047
RUSSELL 200031.2
Others21.8
Top 5 Winners (%)%
aleanna inc
390.5 %
aleanna inc
190.9 %
TNGX
tango therapeutics inc
115.5 %
RVMD
revolution medicines inc
85.1 %
CNTA
centessa pharmaceuticals plc
55.7 %
Top 5 Winners ($)$
RVMD
revolution medicines inc
248.1 M
TNGX
tango therapeutics inc
133.6 M
PTGX
protagonist therapeutics inc
112.8 M
CNTA
centessa pharmaceuticals plc
74.9 M
WAB
wabtec
74.5 M
Top 5 Losers (%)%
SLDP
solid power inc
-69.2 %
beta bionics inc
-61.6 %
blue gold ltd
-54.5 %
NUVB
nuvation bio inc
-52.1 %
RANI
rani therapeutics hldgs inc
-45.6 %
Top 5 Losers ($)$
MSFT
microsoft corp
-258.6 M
BSX
boston scientific corp
-243.0 M
KKR
kkr & co inc
-117.0 M
NTRA
natera inc
-103.6 M
UNH
unitedhealth group inc
-101.8 M

FARALLON CAPITAL MANAGEMENT LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of FARALLON CAPITAL MANAGEMENT LLC

FARALLON CAPITAL MANAGEMENT LLC has 167 stocks in it's portfolio. About 42.7% of the portfolio is in top 10 stocks. MSFT proved to be the most loss making stock for the portfolio. RVMD was the most profitable stock for FARALLON CAPITAL MANAGEMENT LLC last quarter.

$15.34BTotal Value
194Positions
15 May, 2026Last Reported
Current holdings of Current Stock Holdings of FARALLON CAPITAL MANAGEMENT LLC, last reported on 15 May, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
ALVO
Alvotech

Alvotech

ALVO
FARALLON CAPITAL MANAGEMENT LLC's holding in Alvotech over time
0%199,675
$684.9K
0%
unchanged 0 percentunchanged
ASND
Ascendis Pharma A/S

Ascendis Pharma A/S

ASND
FARALLON CAPITAL MANAGEMENT LLC's holding in Ascendis Pharma A/S over time
0%0.00
$0.00
0%
decreased 100 percentsold off